Hammer, S., Sobieszczyk, M., Janes, H., Gilbert, P., Karuna, S., Grove, D., … Corey, L. (2013). HVTN 505: Efficacy of a Multi-Gene DNA Prime/Recombinant Adeno 5 (rAd5) Vector Boost Vaccine in Men & Transgender Women (TGW) Who Have Sex with Men. In AIDS RESEARCH AND HUMAN RETROVIRUSES (Vol. 29, pp. A172–A172). Barcelona, SPAIN: MARY ANN LIEBERT, INC.

Hammer, S., M. Sobieszczyk, H. Janes, P. Gilbert, S. Karuna, D. Grove, S. Ramirez, et al. “HVTN 505: Efficacy of a Multi-Gene DNA Prime/Recombinant Adeno 5 (rAd5) Vector Boost Vaccine in Men & Transgender Women (TGW) Who Have Sex with Men.” In AIDS RESEARCH AND HUMAN RETROVIRUSES, 29:A172–A172. MARY ANN LIEBERT, INC, 2013.

Hammer S, Sobieszczyk M, Janes H, Gilbert P, Karuna S, Grove D, et al. HVTN 505: Efficacy of a Multi-Gene DNA Prime/Recombinant Adeno 5 (rAd5) Vector Boost Vaccine in Men & Transgender Women (TGW) Who Have Sex with Men. In: AIDS RESEARCH AND HUMAN RETROVIRUSES. MARY ANN LIEBERT, INC; 2013. p. A172–A172.

Hammer, S., et al. “HVTN 505: Efficacy of a Multi-Gene DNA Prime/Recombinant Adeno 5 (rAd5) Vector Boost Vaccine in Men & Transgender Women (TGW) Who Have Sex with Men.” AIDS RESEARCH AND HUMAN RETROVIRUSES, vol. 29, no. 11, MARY ANN LIEBERT, INC, 2013, pp. A172–A172.

Hammer S, Sobieszczyk M, Janes H, Gilbert P, Karuna S, Grove D, Ramirez S, Bentley C, Anude C, Mulligan M, Koblin B, Buchbinder S, Keefer M, Hural J, McElrath J, Frahm N, Tomaras G, Graham B, Enama M, Broder G, Maynard J, Wakefield S, Holt R, DeJesus E, Frank I, Novak R, Martinez A, Kublin J, Corey L. HVTN 505: Efficacy of a Multi-Gene DNA Prime/Recombinant Adeno 5 (rAd5) Vector Boost Vaccine in Men & Transgender Women (TGW) Who Have Sex with Men. AIDS RESEARCH AND HUMAN RETROVIRUSES. MARY ANN LIEBERT, INC; 2013. p. A172–A172.